General MedicationsTOPICALStandard
QUTENZA
CAPSAICIN
Standard Dose
8%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview QUTENZA is listed in Drugs@FDA under application 022395 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CAPSAICIN Form and strength PATCH;TOPICAL - 8% Sponsor AVERITAS Submission history Latest submission status date: 2024-07-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview QUTENZA is listed in Drugs@FDA under application 022395 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CAPSAICIN Form and strength PATCH;TOPICAL - 8% Sponsor AVERITAS Submission history Latest submission status date: 2024-07-31 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.